Showing results (151-160 of 536) with videos related to

Sort By:
Pageof 54
Respiratory Research|June 2, 2009
COPD phenotype description using principal components analysisKay Roy, Jacky Smith, Umme Kolsum, et al.
Pulmonary Pharmacology & Therapeutics|September 9, 2014
Daily variation in lung function in COPD patients with combined albuterol and ipratropium: results from a 4-week, randomized, crossover studyDave Singh, Chang-Qing Zhu, Sanjay Sharma, et al.
British Journal of Clinical Pharmacology|November 1, 2014
Corticosteroid insensitive alveolar macrophages from asthma patients; synergistic interaction with a p38 mitogen-activated protein kinase (MAPK) inhibitorSimon Lea, Chris Harbron, Naimat Khan, et al.
British Journal of Clinical Pharmacology|November 8, 2014
Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary diseaseVandana Gupta, Antonia Banyard, Aoibheann Mullan, et al.
Respiratory Research|February 12, 2020
A dose-ranging study of the inhaled dual phosphodiesterase 3 and 4 inhibitor ensifentrine in COPDDave Singh, Fernando J Martinez, Henrik Watz, et al.
Clinical and Experimental Immunology|June 18, 2021
Assessment of bacterial exposure on phagocytic capability and surface marker expression of sputum macrophages and neutrophils in COPD patientsSimon Lea, Rosemary Gaskell, Simon Hall, et al.
Frontiers in Pharmacology|December 10, 2021
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary DiseaseFabrizio Facchinetti, Maurizio Civelli, Dave Singh, et al.
Biomedicines|October 27, 2022
Assessing the Anti-Inflammatory Effects of an Orally Dosed Enzymatically Liberated Fish Oil in a House Dust Model of Allergic AsthmaCrawford Currie, Bomi Framroze, Dave Singh, et al.
British Journal of Clinical Pharmacology|March 18, 2026
Early clinical pharmacology evaluation of the novel anti-inflammatory macrolide, glasmacinal (EP395): tolerability, pharmacokinetics and drug interactionsDave Singh, Kate Hanrott, Olof Breuer, et al.
Breathe (Sheffield, England)|January 29, 2026
Work-life balance as early career respiratory experts and ERS representatives: personal experiences, reflections and potential solutions for improvementMathieu Marillier, Athénaïs Boucly, Matteo Siciliano, et al.
Pageof 54